Contact Us
โ† Back to SureMediks
๐Ÿ“‹ Chronic Disease Intelligence ยท Payers & Insurers

Reduce High-Cost
Chronic Disease Events.
Measure It. Prove It.

SureMediks gives health plans, managed care organisations and insurers the AI infrastructure to risk-stratify chronic disease populations, reduce preventable interventions and generate outcomes data that value-based contracts demand.

๐Ÿ“… Schedule a Health Plan Demo Request ROI Analysis
Healthcare Data Analytics
๐Ÿ’ฐ
30%+
Avoidable cost
reduction
๐Ÿ“Š
95%
Patient maintenance
rate โ€” sustained
$1.5Mโ€“$4M
Savings per 500-patient clinic
Per year, reduced interventions
30%+
Reduction in avoidable costs
AI-guided early intervention
95%
Patient maintenance rate
Sustained outcomes in trial
100%
Patient engagement rate
Every trial participant
Value for Payers

From Risk to Outcomes.
AI-Powered and Measurable.

๐Ÿ“Š

Population Risk Stratification

Identify high-risk chronic disease members before they generate costly acute events. AI risk scoring across continuous biometric data.

๐Ÿ’ฐ

Reduce Preventable Costs

Avoidable hospitalisation, unnecessary specialist referrals and unmanaged chronic disease progression โ€” all addressable through early AI-guided intervention.

๐Ÿ“ˆ

Value-Based Contract Support

Generate the structured, longitudinal real-world outcomes data your value-based care contracts require โ€” same quality as our Springer Nature publication.

๐Ÿ”—

Provider Network Integration

Deploy SureMediks across your contracted provider network via white-label or co-branded programmes. Population-level monitoring at scale.

๐Ÿ“‹

Remote Patient Monitoring (RPM)

CMS-reimbursable RPM infrastructure. Continuous biometric data from multiple device types โ€” all flowing into one AI-analysed platform.

๐ŸŽฏ

Member Engagement & Adherence

Reduce medication non-adherence and programme dropout through AI-personalised guidance. 95% maintenance rate proven in peer-reviewed trial.

Evidence-Based ROI

Outcomes Data at
Payer-Grade Quality

The same platform that generated our Springer Nature 2024 publication is what you deploy across your member population. Publication-grade RWE generation is built in โ€” not an add-on.

  • โœ“391 participants ยท multinational ยท 24 weeks ยท BMI 20โ€“78
  • โœ“14% average weight loss ยท 95% maintenance rate ยท 100% engagement
  • โœ“Published: Obesity Surgery, Springer Nature 2024 โ€” 210 Altmetric
  • โœ“IFSO, ASMBS and Obesity Society presented and recognised
  • โœ“4 patents: Khokhar WL Formula, Predictive Modeling, AI+Expert Hybrid, Engagement Algorithms
๐Ÿ“„
Peer-Reviewed Publication
Obesity Surgery ยท Springer Nature ยท Vol. 34, 2024
391 participants ยท 14% avg. weight loss ยท 100% engaged ยท 95% sustained outcomes
Request an ROI Analysis โ†’
Healthcare Analytics
Chronic Disease Intelligence ยท For Payers

Build a Measurable Chronic
Disease Programme. Today.

Schedule a conversation with our health plan partnerships team.

๐Ÿ“… Schedule a Demo Request ROI Analysis